Newsletter
Language
Language:
 
News
Archival Issues
Volume 18, 2016
Volume 17, 2015
Volume 16, 2014
Volume 15, 2013
Volume 14, 2012
Volume 13, 2011
Volume 12, 2010
Volume 11, 2009
Volume 10, 2008
Volume 9, 2007
Volume 8, 2006
Volume 7, 2005
Volume 6, 2004
Volume 5, 2003
Volume 4, 2002
Volume 3, 2001
Volume 2, 2000
Volume 1, 1999
Search
 » 
Journal Abstract
 
Cost analysis and sociomedical aspects of the conservative and surgical treatment of hip osteoarthritis
Julian Dutka , Łukasz Dutka , Mateusz Janiszewski , Grzegorz Hajduk
Ortop Traumatol Rehabil 2008; 10(6):537-546
ICID: 877573
Article type: Original article
IC™ Value: 7.16
Abstract provided by Publisher
 
Introduction. Hip osteoarthritis (OA) is one of the most common causes of pain, physical disability and marked impairment of patients’ physical fitness and mobility. Insufficient funding for health care contributes to prolonged waiting times for total hip replacement (THR) surgery, which has been proven to be the only effective treatment for OA. Average waiting time in Poland is estimated at 2-2.5 years. Objective. To carry out a retrospective comparative analysis of the cost of THR surgery vs. conservative treatment for OA in a variety of sociomedical aspects while patients are awaiting THR. Material and methods. Two groups of patients were compared. Group I consisted of 77 patients awaiting THR and treated with physical therapy and drugs. Group II consisted of 91 patients who underwent THR. Evaluations and comparisons were based on a modified WOMAC index, the SF-8 survey and estimates of pharmacological, procedural and orthopaedic equipment expenditures. Results. Prolonged waiting times and the associated conservative treatment costs, including drugs, physical therapy, sanatorium, orthopaedic equipment, transport, sickness benefits and costs of pharmacological treatment of complications, were shown to be approximately twice higher compared to the cost of surgical treatment. Apart from financial costs, other significant aspects should also be noted, such as deterioration of the patient’s life quality and psychosocial health, and prolonged anguish. Conclusions. Pharmacological treatment, rehabilitation, physical therapy and other methods appear to be inefficient in patients with hip OA awaiting THR and their costs are twice as high. Additionally, NSAID drugs produce GI ulcers in 25% of the patients. Psychosocial problems are also common for these patients. Surgical treatment produces a radical improvement of the quality of life and ameliorates psychosocial problems. Therefore, hip OA costs can only be reduced by shorter waiting times, which can be accomplished through an increase in funding resulting in wider access to the procedure.

ICID 877573
PMID 19153542 - click here to show this article in PubMed
 
FULL TEXT 373 KB


Related articles
  • in IndexCopernicus™
         koszty leczenia [1 related records]
         alloplastyka całkowita stawu biodrowego [0 related records]
         pharmacoeconomics [4 related records]
         total hip replacement [19 related records]
         conservative treatment [38 related records]
         hip osteoarthritis [2 related records]

  • Related articlesin PubMed database
  • in PubMed database [ related records]


  •  

    Copyright © Ortopedia Traumatologia Rehabilitacja  2017
    Page created by Index Copernicus Ltd. All Rights reserved.